Article
Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
Clinical chemistry and laboratory medicine - 1 Aug 2013
Park Seo-Jin, Sun Je Young Hannah, Hong Kyungran, Kwak Jin Young, Kim Eun-Kyung, Chung Woung Youn, Choi Jong Rak
Abstract excerpt
BACKGROUND: BRAFV600E, the most common BRAF gene mutation, is detected in approximately 50% of sporadic papillary thyroid carcinoma (PTC) and may be associated with triggering tumorigenesis of PTC. The aim of our study was to discover additional mutations to increase the diagnostic performance of molecular tests in screening for thyroid cancer from fine needle aspiration biopsy (FNAB) specimens. METHODS: DNA was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
